{"status": "OK", "response": {"docs": [{"type_of_material": "News", "blog": [], "news_desk": "Health&Fitness", "lead_paragraph": "Older men with low levels of estrogen are at greater risk for hip fractures, a new study reports, and those with low levels of both estrogen and testosterone are at the greatest risk of all. Researchers at Boston University and the Hebrew SeniorLife in Boston examined 793 men with an average age of 71 at the beginning of the research. The participants, followed by these researchers for almost 20 years, were part of the long-term Framingham Heart Study.", "headline": {"main": "For Men, Low Estrogen Level Puts Hips in Peril", "kicker": "VITAL SIGNS: RISK"}, "abstract": "Dr Shreyasee Amin of Mayo Clinic leads study on impact of estrogen on risk of hip fracture; research, which is published in American Journal of Medicine, finds that men with lowest levels of estrogen are three times as likely to sustain hip fractures as men with normal estrogen levels; men with low testosterone and estrogen were six times as likely to fracture hip (M)", "print_page": "6", "word_count": 249, "_id": "4fd2548d8eb7c8105d7fc0e6", "snippet": "Older men with low levels of estrogen are at greater risk for hip fractures, a new study reports, and those with low levels of both estrogen and testosterone are at the greatest risk of all.      Researchers at Boston University and the Hebrew...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://query.nytimes.com/gst/fullpage.html?res=9D03E5DC153EF935A25756C0A9609C8B63", "multimedia": [], "subsection_name": null, "keywords": [{"name": "persons", "value": "AMIN, SHREYASEE"}, {"name": "organizations", "value": "AMERICAN JOURNAL OF MEDICINE"}, {"name": "organizations", "value": "MAYO CLINIC"}, {"name": "subject", "value": "ESTROGEN"}, {"name": "subject", "value": "HORMONES"}, {"name": "subject", "value": "HIPS"}, {"name": "subject", "value": "MEN"}, {"name": "subject", "value": "TESTOSTERONE"}, {"name": "subject", "value": "BONES"}, {"name": "subject", "value": "RESEARCH"}], "byline": {"person": [{"organization": "", "role": "reported", "firstname": "Nicholas", "rank": 1, "lastname": "Bakalar"}], "original": "By Nicholas Bakalar"}, "document_type": "article", "pub_date": "2006-05-16T00:00:00Z", "section_name": "Health"}, {"type_of_material": "News", "blog": [], "news_desk": "Health&Fitness", "lead_paragraph": "Seeing is believing for heart patients. A new study suggests that when patients see a scan showing plaque accumulation in their own arteries, their adherence to a lipid-lowering drug regimen increases significantly. Researchers studied 505 asymptomatic patients on statin therapy who had their arteries examined by electron beam tomography, which produces a picture of arterial plaque. Each patient looked at the actual scan, which clearly showed the artery-blocking plaque as bright white spots.", "headline": {"main": "For Patients, There's Beauty in the Ugly Truth", "kicker": "VITAL SIGNS: MOTIVATION"}, "abstract": "Dr Matthew Budoff of University of California, Los Angeles, leads study that finds people shown degree of plaque accumulation in own arteries are more likely to follow drug regimen suggested by doctor than those only told about blockage; research is published in journal Atherosclerosis; drawing (M)", "print_page": "6", "word_count": 280, "_id": "4fd2548d8eb7c8105d7fc0e4", "snippet": "Seeing is believing for heart patients. A new study suggests that when patients see a scan showing plaque accumulation in their own arteries, their adherence to a lipid-lowering drug regimen increases significantly.      Researchers studied 505...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://query.nytimes.com/gst/fullpage.html?res=9F00E5DC153EF935A25756C0A9609C8B63", "multimedia": [], "subsection_name": null, "keywords": [{"name": "persons", "value": "BUDOFF, MATTHEW"}, {"name": "organizations", "value": "UNIVERSITY OF CALIFORNIA"}, {"name": "organizations", "value": "ATHEROSCLEROSIS"}, {"name": "subject", "value": "HEART"}, {"name": "subject", "value": "PLAQUE"}, {"name": "subject", "value": "DRUGS (PHARMACEUTICALS)"}, {"name": "subject", "value": "DOCTORS"}, {"name": "subject", "value": "RESEARCH"}, {"name": "subject", "value": "TESTS AND TESTING"}], "byline": {"person": [{"organization": "", "role": "reported", "firstname": "Nicholas", "rank": 1, "lastname": "Bakalar"}], "original": "By Nicholas Bakalar"}, "document_type": "article", "pub_date": "2006-05-16T00:00:00Z", "section_name": "Health"}], "meta": {"hits": 2, "offset": 0, "time": 38}}, "copyright": "Copyright (c) 2013 The New York Times Company.  All Rights Reserved."}